Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Factors associated with long-acting injectable antipsychotic selection among psychiatric inpatients.

Created on 20 Nov 2026

Authors

Sean T Lynch, Kathryn B Renard, Angelo I Chaia, Lisa J Cohen, Carisa M Kymisiss

Published in

International clinical psychopharmacology. Nov 17, 2026. Epub Nov 17, 2026.

Abstract

Factors associated with receipt of different long-acting injectable antipsychotics (LAIs) remain incompletely understood. This retrospective study examined 370 psychiatric inpatients receiving LAIs between January 2020 and October 2022. Logistic regression compared first-generation (FGA) versus second-generation (SGA) LAI receipt and paliperidone palmitate versus aripiprazole lauroxil receipt. Fixed-covariate sensitivity analyses excluded inpatient-course variables. Overall, 313 patients received SGA LAIs and 57 received FGA LAIs. In primary models, schizophrenia spectrum and schizoaffective disorders were associated with lower odds of SGA receipt than bipolar spectrum disorders. Substance use was associated with higher odds of SGA receipt, whereas additional discharge psychotropics were associated with lower odds. Among SGA recipients, stimulant use was associated with lower odds of paliperidone receipt (adjusted odds ratio: 0.32, 95% confidence interval: 0.17-0.60), while longer hospitalization and additional discharge psychotropics were associated with higher odds. In sensitivity analyses, schizoaffective and stimulant-use associations persisted, schizophrenia spectrum and any-substance-use associations were not statistically significant. Older age was also associated with paliperidone receipt. These exploratory findings describe differences between LAI prescribing groups, without establishing prescribing rationale or comparative effectiveness. Inpatient-course associations require caution because their temporal relationship to medication selection was uncertain.

PMID:
43056638
Bibliographic data and abstract were imported from PubMed on 20 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement